E. V. Taranov

E. V. Taranov

Auto-generated profile, based on publicly available information

E. V. Taranov

Specialized Cardiosurgical Clinical Hospital named after Academician B. A. Korolev; Privolzhsky Research Medical University; Lobachevsky University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
NPN. K. Pastukhova
N. K. Pastukhova
VPVladimir V. Pichugin
Vladimir V. Pichugin
SFS. A. Fedorov
S. A. Fedorov
YBYu. D. Brichkin
Yu. D. Brichkin
KNK. I. Nikitin
K. I. Nikitin
Introduction. To date, single studies have been published on the anesthesiological support of operations for acute pulmonary embolism. The issues of the influence of basic anesthetics on central hemodynamics and the functional state of lung tissue are not covered.The objective was to conduct a comparative assessment of the effect of anesthesia based on propofol, sevoflurane and desflurane on the parameters of central hemodynamics, myocardial contractility and functional state of the lungs during operations for acute pulmonary embolism.Materials and methods. The study included 75 patients (42 men and 33 women) aged 42.3 ± 14.3 years. All patients were operated for massive pulmonary embolism under cardiopulmonary bypass. The patients were randomized into three groups: in the first group (25 patients), propofol was used as the main anesthetic; in the secondgroup (25 patients) - sevoflurane; in the third group (25 patients) - desflurane. The indicators of central hemodynamics, myocardial contractile function and the functional state of the lungs during the operation were studied.Results. The comparative analysis of the anesthesia revealed that propofol had a more pronounced depressive effect on hemodynamics (a statistically significant decrease in blood pressure and EF LV), and desflurane had a moderate hyperdynamic effect (a statistically significant increase in heart rate). Anesthesia with propofol caused a statistically significant increase in the AAPO2 index (by 32.1%), a decrease in the PaO2/FiO2 index (by 24.1%) before cardiopulmonary bypass. After CPB, the oxygenation index decreased, intrapulmonary blood shunting increased, and pulmonary compliance decreased statistically significantly. The use of inhalation anesthetics (sevoflurane, desflurane) effectively preserved the functional parameters of the lungs: there were no statistically significant changes in the studied parameters.Conclusion. The inclusion of inhaled anesthetics (sevoflurane and desflurane) in the anesthesia regimen during surgery for acute pulmonary embolism ensures the stability of hemodynamic parameters and contractile function of the myocardium. The use of inhaled anesthetics maintains high lung function during surgery.

30 August 2025 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
KNK. I. Nikitin
K. I. Nikitin
AMA. S. Malkina
A. S. Malkina
СФС. А. Федоров
С. А. Федоров
Introduction: Multiple organ dysfunction syndrome (MODS) is a common complication and leading cause of mortality in cardiac surgery patients. To date, effective therapeutic methods and preventive strategies for this condition remain undeveloped. Identification of the role of systemic inflammatory response syndrome (SIRS) as a key component in MODS pathogenesis facilitates the development of novel treatment approaches targeting the disease’s pathogenic mechanisms. The use of new pharmacological agents with anti-inflammatory properties as a part of comprehensive MODS therapy may significantly improve treatment efficacy and clinical outcomes in cardiac surgery patients.Objective: To systematize information on the pathophysiology of MODS, detailing the contribution of SIRS, as well as data on prevention and therapy methods.Materials and methods: In this study, scientific articles relevant to this topic were analyzed through searches of PubMed, Google Scholar, UpToDate, EMBASE databases. The search for relevant articles was performed using the following keywords: “multiple organ dysfunction syndrome”, “systemic inflammatory response syndrome”, “ischemia/reperfusion syndrome”, “mitochondrial failure”, “endothelial dysfunction”, “inhaled nitric oxide”, as well as their Russian equivalents. Inclusion criteria: relevance to selected review topic; alignment with one of the selected study designs (randomized clinical trials, experimental studies, and previously published literature reviews); studies related to a cohort of cardiac surgery patients. Exclusion criteria: studies focused on clinical observations or single case reports; studies with questionable data or results, as determined by analysis using established protocols (PRISMA, STROBE, SANRA, EQUATOR).Results: The following aspects were analyzed: the central role of SIRS as a key factor in the development of MODS; the pathogenesis of MODS, including ischemia-reperfusion injury, endothelial dysfunction, and microcirculatory disorders; and a shift in therapeutic focus from strategies aimed exclusively at replacing organ function to preventive approaches and targeted interventions addressing the underlying pathogenetic mechanisms.Conclusion: Understanding the key aspects of MODS pathogenesis may guide therapeutic progress, by enabling specific targeting of the pathogenetic mechanisms involved in MODS development.

31 October 2026 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
KNK. I. Nikitin
K. I. Nikitin
AMA. S. Malkina
A. S. Malkina
INTRODUCTION: Hyperlactatemia after cardiac surgery with cardiopulmonary bypass (CPB) occurs in 20–40 % of patients and is associated with adverse outcomes. However, distinguishing hypoperfusion from metabolic hyperlactatemia remains difficult because simple routine diagnostic criteria are lacking. OBJECTIVE: To identify clinical phenotypes of postoperative hyperlactatemia, develop routine diagnostic criteria, and assess their association with escalation of inotropic and/or vasopressor support and clinical outcomes. MATERIALS AND METHODS: In this prospective cohort (January–December 2025), 221 of 733 adults undergoing cardiac surgery with CPB developed hyperlactatemia (arterial lactate ≥ 3.0 mmol/L within 6 h); after 41 exclusions, 180 were analyzed. Central venous oxygen saturation (ScvO2), the venous-to-arterial carbon dioxide partial pressure difference (Pv-aCO2), and lactate clearance were assessed. Hyperlactatemia was classified as ischemic or metabolic. Oxygen delivery index (DO2I) was measured in 126 patients. Receiver operating characteristic (ROC) analysis, multivariable logistic regression, and decision curve analysis (DCA) were performed. RESULTS: Hyperlactatemia occurred in 30.2 % of patients; 180 were analyzed. The ischemic phenotype was identified in 92 (51.1 %) patients and the metabolic phenotype in 88 (48.9 %). The ischemic phenotype was associated with higher peak lactate, lower lactate clearance, and more frequent escalation of inotropic and/or vasopressor support (all p < 0.001). In the exploratory ROC analysis, the internal discriminatory performance of a lactate threshold > 4.8 mmol/L was AUC 0.83, while the combination of lactate and ScvO2 yielded an AUC of 0.86. Independent predictors of support escalation were peak lactate, lactate clearance < 10 %, and ScvO2 < 65 %. The proposed criteria agreed with reduced DO2I (< 450 mL/min/m²; κ = 0.78; p < 0.001). Hospital mortality was higher in the ischemic group (7.6 vs 1.1 %; p = 0.03). CONCLUSIONS: Approximately half of patients with postoperative hyperlactatemia exhibited a hypoperfusion phenotype associated with worse outcomes. The combination of lactate > 4.8 mmol/L, ScvO2 < 65 %, Pv-aCO2 > 6 mmHg, and lactate clearance < 10 % may help stratify the probability of a hypoperfusion phenotype.

29 November 2025 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
ETE. V. Taranov
E. V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA. V. Bogush
A. V. Bogush
AMA. S. Malkina
A. S. Malkina
KNK. I. Nikitin
K. I. Nikitin
FMF. H. Mahgob
F. H. Mahgob
Objective : To determine the incidence and structure of postoperative pulmonary complications (PPCs) and to identify independent risk factors for their development in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Materials and Methods : A retrospective single-center study included 658 patients who underwent cardiac surgery in 2024. Demographic, anamnestic, intra- and postoperative data were analyzed. Univariate and multivariate logistic regression analyses were used to identify risk factors for postoperative complications. Results : PPCs were observed in 71 (10.8%) patients. Atelectasis was the most common complication (7.9%). The incidence of PPCs among smokers was 24.5% (compared to 4.1% among non-smokers), and among obese patients – 21.8% (compared to 6.3% in patients with BMI 65 years (OR 6.14; 95% CI 3.38–11.16), CPB duration >120 min (OR 5.86; 95% CI 3.57–9.60), smoking history (OR 5.92; 95% CI 2.89– 12.15), obesity (BMI ≥30 kg/m²; OR 5.12; 95% CI 2.70–9.81), and combined surgery (OR 4.69; 95% CI 2.46–8.94). The presence of chronic obstructive pulmonary disease (OR 1.94; 95% CI 1.11–3.39) and pulmonary hypertension (OR 2,14; 95% CI 1.79–5.52) was also associated with an increased risk (all p < 0.001). Conclusions : The identified modifiable risk factors (smoking, obesity) highlight the importance of preoperative optimization. Nonmodifiable factors (age, type of surgery) define a high-risk group requiring increased attention and early prevention of PPC. The findings may contribute to the development of risk stratification algorithms in cardiac surgery practice.

15 May 2026 in Regional Anesthesia and Acute Pain Management
Verified
Journal Article
Closed access
PDF file
ETEvgeny V. Taranov
Evgeny V. Taranov
ТВТаранов Евгений Владимирович
Таранов Евгений Владимирович
AMAlina S. Malkina
Alina S. Malkina
МСМалкина Алина Сергеевна
Малкина Алина Сергеевна
VTValeriya P. Tyundina
Valeriya P. Tyundina
НИНикитин Клим Ильич
Никитин Клим Ильич
The historical paradigm of cardiac anesthesia, reliant on high-dose opioids, carries inherent risks of prolonged mechanical ventilation, increased complications, and extended hospital stays. The contemporary shift towards minimally invasive surgery and the widespread adoption of Enhanced Recovery After Surgery (ERAS) protocols necessitates a move from deep sedation towards the active control of the perioperative stress response, thereby redefining the role of regional anesthesia (RA). This review aims to provide a detailed analysis of the evolution, evidence base, and clinical significance of regional anesthesia techniques within multimodal ERAS strategies in cardiac anesthesia practice. A systematic literature search was conducted following PRISMA guidelines across PubMed/MEDLINE, Embase, Cochrane CENTRAL, and other databases (January 2000 — March 2025). After a two-stage screening process, 46 publications were included for final analysis. Due to significant clinical heterogeneity among the studies, a structured narrative synthesis was performed. The results show that regional anesthesia has evolved from an adjunct analgesic technique into a strategic pillar of anesthetic management. Its fundamental advantage — the preemptive blockade of nociceptive afferentation — enables effective modulation of the surgical stress response. The integration of RA into ERAS protocols demonstrably promotes hemodynamic stability, reduces pulmonary complications, provides effective analgesia with minimal opioid use, shortens extubation time and ICU stay, and ultimately accelerates functional patient recovery. Thus, regional anesthesia serves as a cornerstone of modern multimodal cardiac anesthesia aligned with the ERAS philosophy, and the proactive use of contemporary ultrasound-guided RA techniques is helping to establish a new standard of care focused on improving perioperative outcomes, patient safety, and quality of life following cardiac surgery.

4 June 2026 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
ETE.V. Taranov
E.V. Taranov
VPVladimir V. Pichugin
Vladimir V. Pichugin
ABA.V. Bogush
A.V. Bogush
SFS.A. Fedorov
S.A. Fedorov
KNK.I. Nikitin
K.I. Nikitin
MDM.S. Davydov
M.S. Davydov
Background. Patients with acute heart failure (AHF) and cardiogenic shock requiring cardiac surgery represent the cohort of the highest risk with extremely poor perioperative outcomes. Standard risk stratification tools (EuroSCORE II, STS scores) consistently underestimate mortality in this population, necessitating integration of additional prognostic modalities including biomarkers and dynamic hemodynamic assessment. Objective. To analyze current evidence on optimizing perioperative management of patients with AHF and cardiogenic shock. Material and methods. A systematic review was performed across PubMed, Embase, Cochrane Library, and Google Scholar databases (2000—2025). Systematic reviews, meta-analyses, randomized controlled trials, and large cohort studies addressing perioperative management of adults with AHF or cardiogenic shock undergoing cardiac surgery were included. Among 410 initially identified records, 35 studies met inclusion criteria after screening and full-text assessment. Results. In addition to EuroSCORE II, modern approach includes assessment of biomarkers (ST2 protein, galectin-3, NT-proBNP), perfusion parameters (lactate, central venous saturation (ScvO2), and cardiogenic shock-specific assessment (SCAI). The choice of anesthesia is driven by the need for hemodynamic stability, not by a debate about support methods. Hybrid and minimally invasive procedures instead of open surgery are justified. Perfusion modification (MECC, pulsatile mode) reduces inflammatory response and improves organ perfusion. Intensive care strategy should be preemptive with early planning of mechanical circulatory support (extracorporeal membrane oxygenation) and multiple organ support. Conclusion. Perioperative management of cardiac surgery patients with acute heart failure should be based on a multidisciplinary approach including advanced risk assessment, individual choice of surgical tactics and anesthesia, modified perfusion and preventive intensive care.